Clinical study of shuangshenlong capsule combined with amlodipine in the treatmentof vasospasm angina pectoris
双参龙胶囊联合氨氯地平治疗血管痉挛性心绞痛的临床研究

摘要

目的 分析血管痉挛性心绞痛患者使用双参龙胶囊联合氨氯地平进行治疗的效果。方法 从2020年1月-2022年1月时间内因血管痉挛性心绞痛入院的患者内随机选择60例，依据治疗形式分组，即实验与对照，各组病患为30例。对照组病患使用氨氯地平治疗，实验组病患联合双参龙胶囊，对比效果。结果 实验组疗效优于对照组，P＜0.05。治疗后，实验组相关指标优于对照组，P＜0.05。实验组症状缓解时间优于对照组，P＜0.05。治疗前，两组炎性因子无差异，P＞0.05。治疗后，实验组炎性因子均优于对照组，P＜0.05。结论 对血管痉挛性心绞痛患者使用双参龙胶囊联合氨氯地平治疗，可提升疗效，改善症状。

Abstract

Objective to analyze the therapeutic effect of shuangshenlong capsule combined with amlodipine on patients with vasospasm angina pectoris.
Methods from January 2020 to January 2022, 60 patients with vasospasm angina pectoris were randomly selected and grouped according to the treatment form, i.e. experiment and control. There were 30 patients in each group. The patients in the control group were treated with amlodipine, and the patients in the experimental group were combined with shuangshenlong capsule to compare the effects.
Results the curative effect of the experimental group was better than that of the control group (P<0.05). After treatment, the relevant indexes of the experimental group were better than those of the control group (P<0.05). The symptom relief time of the experimental group was better than that of the control group (P<0.05). Before treatment, there was no difference in inflammatory factors between the two groups (P>0.05). After treatment, the inflame- matory factors in the experimental group were better than those in the control group (P<0.05).
Conclusion   shuangshenlong capsule combined with amlodipine can improve the curative effect and symptoms of patients with vasospasm angina pectoris.